Clinical Trial Update: Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports the study of nedaplatin combined with docetaxel for advanced lung squamous cell carcinoma; the trial status is Comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Squamous Cell Carcinoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Jiebaishu (nedaplatin)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Squamous Cell Carcinoma | Phase 4 | Status: COMPLETED